Health· 27 Aug 2026FDA Approves First-of-Its-Kind Targeted Therapy for Metastatic Pancreatic CancerThe FDA has approved a first-in-class targeted treatment for metastatic pancreatic cancer after a major trial showed substantially longer median survival than standard chemotherapy.
